학술논문

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
Document Type
Article
Source
In: Vaccine. (Vaccine, 27 February 2024, 42(6):1332-1341)
Subject
Language
English
ISSN
18732518
0264410X